Multidrug resistance markers P-glycoprotein, multidrug resistance protein 1, and lung resistance protein in non-small cell lung cancer: prognostic implications

Walter Berger; Ulrike Setinek; Peter Hollaus; Thomas Zidek; Elisabeth Steiner; L. Elbling; H. Cantonati; Johannes Attems; Andrea Gsur; Michael Micksche

首页> 外文期刊>Journal of Cancer Research and Clinical Oncology >Multidrug resistance markers P-glycoprotein, multidrug resistance protein 1, and lung resistance protein in non-small cell lung cancer: prognostic implications

【24h】

Multidrug resistance markers P-glycoprotein, multidrug resistance protein 1, and lung resistance protein in non-small cell lung cancer: prognostic implications

机译：非小细胞肺癌中多药耐药标志物P-糖蛋白，多药耐药蛋白1和肺耐药蛋白的预后意义

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

The aim of this retrospective study was to comparatively investigate the expression of the three drug-resistance genes P-glycoprotein (P-gp), multidrug-resistance protein 1 (MRP1), and lung resistance protein (LRP), in non-small cell lung cancer (NSCLC) tissues, and to assess possible associations with clinicopathologic features.

机译：这项回顾性研究的目的是比较研究非小细胞中三种耐药基因P-糖蛋白（P-gp），多药耐药蛋白1（MRP1）和肺耐药蛋白（LRP）的表达肺癌（NSCLC）组织，并评估与临床病理特征的可能关联。

著录项

来源
《Journal of Cancer Research and Clinical Oncology》 |2005年第6期|355-363|共9页
作者
Walter Berger; Ulrike Setinek; Peter Hollaus; Thomas Zidek; Elisabeth Steiner; L. Elbling; H. Cantonati; Johannes Attems; Andrea Gsur; Michael Micksche;
展开▼
作者单位

Divisions of Applied Experimental Oncology Institute of Cancer Research Medical University Vienna;

Institute for Pathology and Bacteriology Otto Wagner Hospital Baumgartner Höhe;

Department of Thoracic Surgery Otto Wagner Hospital Baumgartner Höhe;

Division of Epidemiology Institute of Cancer Research Medical University Vienna;

Divisions of Applied Experimental Oncology Institute of Cancer Research Medical University Vienna;

Divisions of Applied Experimental Oncology Institute of Cancer Research Medical University Vienna;

Institute for Pathology and Bacteriology Otto Wagner Hospital Baumgartner Höhe;

Institute for Pathology and Bacteriology Otto Wagner Hospital Baumgartner Höhe;

Divisions of Applied Experimental Oncology Institute of Cancer Research Medical University Vienna;

Divisions of Applied Experimental Oncology Institute of Cancer Research Medical University Vienna;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词
Non-small cell lung cancer; Multidrug resistance; P-glycoprotein; MRP1; LRP;

机译：非小细胞肺癌;多药耐药;P-糖蛋白;MRP1;LRP;

相似文献

外文文献
中文文献
专利

1. Multidrug resistance markers P-glycoprotein, multidrug resistance protein 1, and lung resistance protein in non-small cell lung cancer: prognostic implications. [J] . Berger W, Setinek U, Hollaus P, Journal of Cancer Research and Clinical Oncology . 2005,第6期

机译：非小细胞肺癌中多药耐药标记物P-糖蛋白，多药耐药蛋白1和肺耐药蛋白的预后意义。
2. Multidrug resistance in small cell lung cancer: expression of P-glycoprotein, multidrug resistance protein 1 and lung resistance protein in chemo-naive patients and in relapsed disease. [J] . Triller N, Korosec P, Kern I, Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2006,第2期

机译：小细胞肺癌中的多药耐药性：未经化学治疗的患者和复发性疾病中P-糖蛋白，多药耐药蛋白1和肺耐药蛋白的表达。
3. Expression of multidrug resistance proteins P-glycoprotein, multidrug resistance protein 1, breast cancer resistance protein and lung resistance related protein in locally advanced bladder cancer treated with neoadjuvant chemotherapy: biological and [J] . Diestra JE, Condom E, Del Muro XG, The Journal of Urology . 2003,第4aPta1期

机译：新辅助化疗治疗局部晚期膀胱癌中多药耐药蛋白P-糖蛋白，多药耐药蛋白1，乳腺癌耐药蛋白和肺耐药相关蛋白的表达
4. bcl-2 anti-apoptotic oncoprotein suppresses angiogenesis in non-small cell lung cancer: implications in resistance to photodynamic treatment? [C] . Author(s): M.I. Koukourakis Univ. Hospital of Iraklion (Greece) and Saint Savvas Hospital Iraklion Greece, A.Giatromanolaki Univ. Hospital of Iraklion (Greece) and Saint Savvas Hospital Iraklion Greece, J.Skarlatos Univ. Hospital of Iraklion (Greece) and Saint Savvas Hospital Iraklion Greece, GR-I international conference on new Laser technologies and applications . 1997

机译：bcl-2抗凋亡癌蛋白抑制非小细胞肺癌的血管生成：对光动力治疗的抵抗性有何影响？
5. Marine sponge-derived sipholane triterpenoids reverse P-glycoprotein (ABCB1)-mediated multidrug resistance in cancer cells [D] . Abraham, Ioana 2012

机译：海洋海绵衍生的七环素三萜类化合物逆转癌细胞中的P-糖蛋白（ABCB1）介导的多药耐药性
6. Prognostic Significance of Multidrug Resistance Gene 1 (MDR1) Multidrug Resistance-related Protein (MRP) and Lung Resistance Protein (LRP) mRNA Expression in Acute Leukemia [O] . Hee Jin Huh, Chan-Jeoung Park, Seongsoo Jang, 2006

机译：急性白血病中多药耐药基因1（MDR1）多药耐药相关蛋白（MRP）和肺耐药蛋白（LRP）mRNA表达的预后意义
7. RNA expression of breast cancer resistance protein, lung resistance-related protein, multidrug resistance-associated proteins 1 and 2, and multidrug resistance gene 1 in breast cancer: correlation with chemotherapeutic response [O] . Burger H. (Herman), Foekens J.A. (John), Look M.P. (Maxime), 2003

机译：乳腺癌中乳腺癌耐药蛋白，肺耐药相关蛋白，多药耐药相关蛋白1和2以及多药耐药基因1的RNA表达：与化疗反应的相关性
8. Regulation of Multidrug Resistance Phenotype and P-Glycoprotein Activity in MCF-7 Cells by the Epithelial Na+ Channel [R] . Awayda, M. S. 2004

机译：上皮Na +通道对mCF-7细胞多药耐药表型和p-糖蛋白活性的调节

Multidrug resistance markers P-glycoprotein, multidrug resistance protein 1, and lung resistance protein in non-small cell lung cancer: prognostic implications

摘要

著录项

相似文献

相关主题

期刊订阅